FIELD: biotechnology. SUBSTANCE: liposomal vesicle with lipid envelope consisting of lecithin and cholesterol and can be used in medicine, in part, in pharmacology. Lipid envelope of vesicle has additionally a mixture of acid phospholipids. Indicated mixture is isolated as a united negatively charged phospholipid component from soybean phosphatides. Vesicle has additionally incapsulated cytochrome c taken at ratio to lipid envelope (mas. p. p.) = 1:(6-8). Lipid envelope of vesicle can has additionally tocopherol taken at amount 1.1-2.2% of total lipid envelope mass. EFFECT: enhanced therapeutic effectiveness and prolonged effect as compared with native form of cytochrome c. 3 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD OF LIPOSOME PREPARATION | 1994 |
|
RU2071765C1 |
METHOD OF LYOPHILIZED LIPOSOME PREPARING | 1997 |
|
RU2144352C1 |
LIPOSOME VESICLE | 1993 |
|
RU2084219C1 |
AGENT FOR PROPHYLAXIS OF INFECTIOUS LARYNGOTRACHEITIS IN POULTRY | 1998 |
|
RU2138290C1 |
PHARMACEUTICAL COMPOSITION FOR CONTROLLED RELEASE OF WEAK ACID DRUGS AND ITS USE | 2019 |
|
RU2810790C2 |
METHOD OF OBTAINING MAGNETOSENSITIVE LIPOSOMES | 2007 |
|
RU2357724C1 |
WETTING REGENERATION CREAM AND METHOD OF PREPARATION THEREOF | 1998 |
|
RU2139041C1 |
LIPOSOMAL AGENT BASED ON UBIQUINOL AND PREPARATION METHOD THEREOF | 2015 |
|
RU2605616C1 |
LIPOSOMAL COMPOSITIONS USED FOR DRUG DELIVERY | 2015 |
|
RU2757110C2 |
METHOD OF LIPOSOMAL INTERFERON PREPARING | 1995 |
|
RU2125887C1 |
Authors
Dates
1998-05-20—Published
1994-07-14—Filed